Return On Equity of Cell Source, Inc. from 30 Jun 2014 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cell Source, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2014 to 30 Sep 2024.
  • Cell Source, Inc. Return On Equity for the quarter ending 30 Sep 2024 was 30%, a 21% decline year-over-year.
  • Cell Source, Inc. annual Return On Equity for 2023 was 35%, a 23% decline from 2022.
  • Cell Source, Inc. annual Return On Equity for 2022 was 46%, a 19% decline from 2021.
  • Cell Source, Inc. annual Return On Equity for 2021 was 56%, a 15% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Cell Source, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 30% -8.3% -21% 01 Jul 2024 30 Sep 2024
Q2 2024 31% -9.7% -24% 01 Apr 2024 30 Jun 2024
Q1 2024 31% -14% -31% 01 Jan 2024 31 Mar 2024
Q4 2023 35% -11% -23% 01 Oct 2023 31 Dec 2023
Q3 2023 39% -5.1% -12% 01 Jul 2023 30 Sep 2023
Q2 2023 41% -10% -20% 01 Apr 2023 30 Jun 2023
Q1 2023 45% -7.4% -14% 01 Jan 2023 31 Mar 2023
Q4 2022 46% -10% -19% 01 Oct 2022 31 Dec 2022
Q3 2022 44% -20% -31% 01 Jul 2022 30 Sep 2022
Q2 2022 51% -13% -20% 01 Apr 2022 30 Jun 2022
Q1 2022 52% -17% -24% 01 Jan 2022 31 Mar 2022
Q4 2021 56% -9.7% -15% 01 Oct 2021 31 Dec 2021
Q3 2021 64% +3.1% +5.1% 01 Jul 2021 30 Sep 2021
Q2 2021 64% -2.4% -3.7% 01 Apr 2021 30 Jun 2021
Q1 2021 69% +2.6% +4% 01 Jan 2021 31 Mar 2021
Q4 2020 66% -16% -20% 01 Oct 2020 31 Dec 2020
Q3 2020 60% -26% -30% 01 Jul 2020 30 Sep 2020
Q2 2020 66% +1.1% +1.7% 01 Apr 2020 30 Jun 2020
Q1 2020 66% +14% +27% 01 Jan 2020 31 Mar 2020
Q4 2019 82% +44% +114% 01 Oct 2019 31 Dec 2019
Q3 2019 86% +48% +125% 01 Jul 2019 30 Sep 2019
Q2 2019 65% +24% +58% 01 Apr 2019 30 Jun 2019
Q1 2019 52% +0.88% +1.7% 01 Jan 2019 31 Mar 2019
Q4 2018 38% -21% -35% 01 Oct 2018 31 Dec 2018
Q3 2018 38% +18% +94% 01 Jul 2018 30 Sep 2018
Q2 2018 41% +18% +81% 01 Apr 2018 30 Jun 2018
Q1 2018 51% +32% +166% 01 Jan 2018 31 Mar 2018
Q4 2017 59% +45% +324% 01 Oct 2017 31 Dec 2017
Q3 2017 20% -25% -55% 01 Jul 2017 30 Sep 2017
Q2 2017 23% -23% -51% 01 Apr 2017 30 Jun 2017
Q1 2017 19% -29% -60% 01 Jan 2017 31 Mar 2017
Q4 2016 14% -35% -71% 01 Oct 2016 31 Dec 2016
Q3 2016 44% -28% -39% 01 Jul 2016 30 Sep 2016
Q2 2016 46% -42% -48% 01 Apr 2016 30 Jun 2016
Q1 2016 49% -78% -61% 01 Jan 2016 31 Mar 2016
Q4 2015 49% -163% -77% 01 Oct 2015 31 Dec 2015
Q3 2015 72% -193% -73% 01 Jul 2015 30 Sep 2015
Q2 2015 89% -381% -81% 01 Apr 2015 30 Jun 2015
Q1 2015 126% 01 Jan 2015 31 Mar 2015
Q4 2014 211% 01 Oct 2014 31 Dec 2014
Q3 2014 265% 01 Jul 2014 30 Sep 2014
Q2 2014 470% 01 Apr 2014 30 Jun 2014

Cell Source, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 35% -11% -23% 01 Jan 2023 31 Dec 2023
2022 46% -10% -19% 01 Jan 2022 31 Dec 2022
2021 56% -9.7% -15% 01 Jan 2021 31 Dec 2021
2020 66% -16% -20% 01 Jan 2020 31 Dec 2020
2019 82% +44% +114% 01 Jan 2019 31 Dec 2019
2018 38% -21% -35% 01 Jan 2018 31 Dec 2018
2017 59% +45% +324% 01 Jan 2017 31 Dec 2017
2016 14% -35% -71% 01 Jan 2016 31 Dec 2016
2015 49% -163% -77% 01 Jan 2015 31 Dec 2015
2014 211% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.